Merck Executive and Leadership Team

Rossy Flores, the Chief Financial Officer Merck México at Merck, directs all financial planning, reporting, and fiscal strategy within the Mexican market. Overseeing capital management and regulatory compliance, the Chief Financial Officer Merck México ensures the financial health of regional operations while supporting broader corporate objectives. This leadership role involves analyzing market trends to optimize cost structures and enhance profitability across the pharmaceutical and chemical portfolios. By providing critical financial oversight, Rossy Flores directly impacts the company's ability to invest in local infrastructure and market expansion. The Chief Financial Officer Merck México collaborates with regional leadership to mitigate financial risks and ensure sustainable growth. Through rigorous fiscal discipline, Flores maintains the integrity of financial reporting and supports the strategic goals of the organization. This executive role remains essential for navigating the complex economic landscape of the region while driving long-term value creation.

Rogier Janssens, the President, Merck (China) at Merck, directs all business activities and strategic growth initiatives within the Chinese market. Overseeing the expansion of pharmaceutical and life sciences operations, the President, Merck (China) ensures that the company effectively addresses the unique demands of the regional healthcare landscape. This leadership role involves managing relationships with local partners and government entities to facilitate market access and innovation. By driving operational excellence across research and commercial divisions, Rogier Janssens directly impacts the company's footprint in Asia. The President, Merck (China) coordinates with global leadership to align regional performance with the overarching corporate mission. Through strategic market development, Janssens secures the company's position as a leader in the chemical and pharmaceutical sectors. This executive leadership ensures that the organization remains agile and responsive to the rapid changes within the regional market environment.

Elisaul Hernandez, the Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America at Merck, directs the commercialization of oncology therapies and regional strategic planning. Overseeing market access and brand positioning, the Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America ensures that life-saving treatments reach patients across Latin American markets. This leadership role involves coordinating with research teams to translate clinical data into actionable marketing strategies. By driving regional operational excellence, Elisaul Hernandez directly impacts the company's revenue growth and market penetration in the pharmaceutical sector. The Chief Marketing Officer, Oncology & Head of Strategy & Operations For Latin America manages complex stakeholder relationships to foster sustainable growth. Through data-driven decision-making, Hernandez optimizes the deployment of resources to address specific regional healthcare needs while maintaining high standards of therapeutic efficacy.

Kimberley Brokaw, the Merck Research Laboratories IT & Investment Lead Chief of Staff at Merck, directs the technological infrastructure and capital allocation for research and development. Overseeing the digital transformation of laboratory workflows, the Merck Research Laboratories IT & Investment Lead Chief of Staff ensures that data-driven insights accelerate drug discovery processes. This leadership role involves managing investment portfolios to prioritize high-impact scientific projects across global research centers. By aligning IT capabilities with research goals, Kimberley Brokaw directly impacts the efficiency and output of the company's pharmaceutical innovation pipeline. The Merck Research Laboratories IT & Investment Lead Chief of Staff coordinates with executive leadership to streamline operational budgets and resource distribution. Through strategic oversight of technological investments, Brokaw maintains the company's competitive edge in the life sciences industry, ensuring that research teams possess the necessary tools to address complex medical challenges.

Yaser Alhagan, the Managing Director at Merck, directs all corporate operations and strategic initiatives across the organization. Overseeing the integration of pharmaceutical and life sciences divisions, the Managing Director ensures alignment with long-term growth objectives. This leadership role involves managing complex cross-functional teams to maintain market competitiveness in Europe, Africa, and the Americas. By optimizing internal processes and resource allocation, Yaser Alhagan directly impacts the company's ability to deliver high-quality chemical and healthcare products. The Managing Director maintains close collaboration with the board to refine corporate governance and operational efficiency. Through rigorous oversight of regional performance, Alhagan secures the stability of the global supply chain. This executive leadership ensures that the company remains at the forefront of scientific innovation while meeting the evolving demands of the international healthcare market.